bims-toxgon Biomed News
on Toxoplasma gondii metabolism
Issue of 2026–03–15
thirteen papers selected by
Lakesh Kumar, BITS Pilani



  1. PLoS Negl Trop Dis. 2026 Mar 13. 20(3): e0014108
      Toxoplasma gondii (T. gondii) is an opportunistic protozoan parasite capable of infecting nearly all warm-blooded animals, including humans. Infection with T. gondii often triggers potent inflammatory responses that can lead to severe and potentially life-threatening tissue damage. Based on the mechanistic relationship between the gut microbiota and the host immune system, this study explores the metabolic regulatory network orchestrated by the gut microbiota during T. gondii infection. Using intraperitoneal infection models with both a wild-type ME49 strain and an attenuated ME49Δα-amy strain, we report for the first time a pivotal role for N-acetyl-D-glucosamine (GlcNAc) in modulating parasite-induced inflammation. Integrated analysis of 16S rRNA sequencing and metabolomic profiling revealed that GlcNAc, a gut microbiota-associated metabolite, was significantly enriched in mice infected with the ME49Δα-amy strain. Exogenous administration of GlcNAc to T. gondii-infected mice resulted in the marked downregulation of key pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6, and IL-12, and a significant upregulation of the anti-inflammatory cytokines IL-10 and TGF-β. Moreover, GlcNAc treatment substantially reduced parasite burden and alleviated infection-associated weight loss. These findings not only elucidate the immunomodulatory function of microbiota-related metabolites in the context of zoonotic parasitic infections but also provide a novel theoretical foundation for the development of microbiota-targeted therapeutic strategies against toxoplasmosis. Collectively, our work offers important insights that may inform public health interventions aimed at controlling and preventing zoonotic parasitic diseases.
    DOI:  https://doi.org/10.1371/journal.pntd.0014108
  2. PLoS Negl Trop Dis. 2026 Mar;20(3): e0014077
       BACKGROUND: Chronic infection of Toxoplasma gondii (T. gondii) induces the anxiety-like behavior in hosts, which is closely linked to neuroinflammatory processes. Cis-aconite decarboxylase 1 (Acod1) is an enzyme that is responsible for itaconate production in Krebs Cycle. Emerging evidence highlights the Acod1/itaconate axis as a key regulatory node in macrophage immune-metabolic reprogramming. However, its role in infection-induced neurobehavioral alterations remains unclear. Here, we investigated the role of Acod1/itaconate axis in the anxiety induced by T. gondii chronic infection in mice.
    METHODS: To assess anxiety-like behaviors, we performed open field test and elevated plus maze test. Transcriptomic alterations and neuroinflammatory responses in the mouse amygdala were profiled via RNA sequencing, immunofluorescence staining, quantitative PCR (qPCR), and western blot. The functional role of the Acod1/itaconate axis was further investigated using Acod1-/- mice. Additionally, the therapeutic potential of dimethyl itaconate (DI), a cell-permeable itaconate derivative, was evaluated in chronically T. gondii-infected mice. The levels of indoleamine 2,3-dioxygenase (IDO), and serotonin (5-hydroxytryptamine, 5-HT) in serum were measured by enzyme-linked immunosorbent assay. Finally, DI's anti-inflammatory mechanism was identified in the microglial cell line BV-2 cells.
    RESULTS: Chronic T. gondii infection induced anxiety-like behaviors in mice and triggered the activation of Acod1/itaconate axis in the amygdala. Transcriptomic and histological analyses revealed upregulation of neuroinflammation-related genes, along with microglia activation. Genetic knockout of Acod1 induced the anxiety-like phenotypes, which were rescued by DI administration. Notably, DI treatment conferred both prophylactic and therapeutic benefits, effectively mitigating anxiety induced by infection. Mechanistically, DI suppressed T. gondii-induced M1 polarization in microglia to mitigate neuroinflammation via activating Nrf2 signaling. These events further reduced indoleamine IDO expression, leading to increased 5-HT levels and subsequent amelioration of anxiety-like behavior.
    CONCLUSIONS: Our findings demonstrate that the Acod1/itaconate axis plays an important role in regulating anxiety-like behavior by modulating neuroinflammation during chronic T. gondii infection. These results reveal a promising immune-metabolic drug target for treating T. gondii-associated neuropsychiatric conditions.
    DOI:  https://doi.org/10.1371/journal.pntd.0014077
  3. Drug Dev Res. 2026 Apr;87(2): e70256
      SIRT2, the cytoplasmic member of the sirtuin family, is generally acknowledged to promote cancer and contribute to the progression of various pathologies, including neurodegeneration, inflammation, obesity, and bacterial infection through the deacetylation of target substrates. In our previous efforts we identified potent and highly selective SIRT2 inhibitors with IC50 values in the micromolar range. To further optimize their activity, we performed molecular docking-guided design and subsequent synthesis of a series of novel 1,3,4-thiadiazole derivatives. SIRT inhibitory screening identified that ST131 and ST132 achieved moderate inhibitory effects against SIRT2 with IC50 values of 8.95 and 6.62 µM, respectively. Moreover, cellular assays in MCF-7 breast cancer cells revealed that ST132 has shown an antiproliferative effect, as well as increased acetylated α-tubulin expression levels, which is typically consistent with SIRT2 inhibition. In addition, docking studies were performed to analyze and rationalize the structural differences responsible for SIRT2 activity, shedding light on the importance of the interactions occurring at the entrance of the binding site. Finally, molecular mechanics-generalized born surface area (MM-GBSA) and molecular dynamics (MD) simulation approaches were conducted to verify the stability of ST132 in the complex with SIRT2.
    Keywords:  MCF‐7; sirtuin; thiadiazole; α‐tubulin
    DOI:  https://doi.org/10.1002/ddr.70256
  4. Molecules. 2026 Feb 25. pii: 773. [Epub ahead of print]31(5):
      Metabolic reprogramming and epigenetic remodeling are critical features of tumorigenesis. The process of metabolic reprogramming causes metabolites like Succinyl-CoA to accumulate. Succinylation, which depends on succinyl-CoA as the direct donor group, plays a crucial role in regulating cancer metabolism. This involves the transfer of the succinyl group to the lysine residues of substrate proteins resulting in the alteration of the conformation and function of the proteins, modulating several signaling pathways, many of them involved in metabolism. There is growing evidence that succinylation can alter the activity and stability of metabolic enzymes and reshape metabolic networks. Furthermore, it precisely regulates gene expression through the epigenetic modification mechanisms of the histones and non-histone proteins. Lysine succinylation is thus a crucial hub linking tumor metabolic reprogramming and epigenetic remodeling. This review systematically summarizes the dynamic regulatory mechanisms of lysine succinylation and its critical roles in tumor metabolic reprogramming and epigenetic regulation. In the end, we discuss the crosstalk between succinylation and other post-translational modifications (PTMs) as well as recent advances in cancer therapies targeting succinylation.
    Keywords:  cancer; epigenetic modification; lysine succinylation; metabolic reprogramming; succinyl-CoA
    DOI:  https://doi.org/10.3390/molecules31050773
  5. Int J Biol Sci. 2026 ;22(5): 2702-2719
      Sirtuin 1 (SIRT1) and Sirtuin 2 (SIRT2) are NAD⁺-dependent deacetylases that regulate cancer metabolic stress, exerting their effects primarily through post-translational modification of metabolic enzymes and transcription factors. They modulate glucose, lipid, and mitochondrial metabolism, as well as immune metabolism responses within the tumor microenvironment. Depending on cellular context, they can promote or suppress tumor growth by directing energy production, redox balance, and metabolic adaptation. These context-dependent and often opposing activities constitute a Yin-Yang mode of regulation in cancer metabolism, reflecting a dynamic balance between metabolic activation and constraint. Autophagy has emerged as a critical metabolic integration node regulated by both SIRT1 and SIRT2, linking nutrient sensing, mitochondrial quality control, and stress adaptation. This review summarizes recent advances in understanding how SIRT1 and SIRT2 coordinate tumor metabolism and discusses therapeutic strategies that target their regulatory balance to reprogram cancer metabolism. SIRT2 also functions as a metabolic checkpoint that restrains CD8⁺ T cell effector metabolism, providing a rationale for combining SIRT2 inhibition with immune checkpoint blockade in metabolically stressed tumor microenvironments.
    Keywords:  SIRT1 and SIRT2; glucose metabolism; lipid metabolism; mitochondrial metabolism; tumor immune microenvironment
    DOI:  https://doi.org/10.7150/ijbs.127696
  6. Protein Expr Purif. 2026 Mar 07. pii: S1046-5928(26)00037-9. [Epub ahead of print] 106914
      Toxoplasma gondii infects both humans and animals, causing severe clinical manifestations. Due to the lack of a safe vaccine, the development of a safe and effective vaccine against toxoplasmosis remains a significant need. Saccharomyces cerevisiae is a well-established recombinant protein expression system with Generally Recognized as Safe status. It supports post-translational glycosylation and is employed in several licensed vaccines, including hepatitis B (Engerix-B), human papillomavirus (Gardasil), and malaria (Mosquirix). Recombinant T. gondii proteins expressed in S. cerevisiae have been explored for use in vaccine formulations. However, cell disruption during downstream processing presents a major challenge due to the robust cell wall of yeast. In our previous work, T. gondii recombinant ROP6 protein was successfully expressed in S. cerevisiae INVSc1 cells for use as a vaccine antigen, and cell disruption was performed using a microfluidizer. In this study, we compared the efficiency of four disruption methods (microfluidizer, acid-washed glass beads, liquid nitrogen, and Y-PER reagent) for releasing recombinant protein. The results demonstrated that the microfluidizer and acid-washed glass bead methods achieved superior cell wall disruption efficiency, making them suitable for large-scale processing. The liquid nitrogen method caused excessive protein degradation and presents safety and scalability challenges. Although Y-PER reagent yielded lower amounts of rROP6 protein compared to microfluidizer and acid-washed glass bead methods, it provided good protein stability by reducing multimerization and degradation and offered operational simplicity. Overall, the choice of disruption method should be guided by the target protein's characteristics, production scale, and cost considerations to optimize yield and stability.
    Keywords:  INVSc1 strain; ROP6; Recombinant Protein Production; Rhoptry; Saccharomyces cerevisiae; Toxoplasma gondii; Yeast cell wall disruption methods
    DOI:  https://doi.org/10.1016/j.pep.2026.106914
  7. Arch Biochem Biophys. 2026 Mar 11. pii: S0003-9861(26)00063-9. [Epub ahead of print] 110792
      Acetyl Coenzyme A (acetyl CoA) is a core metabolite that is involved in various interlinked metabolic pathways. Its levels within distinct subcellular compartments reflect the overall metabolic energy status of the cells. Acetyl CoA serves diverse cellular roles, including as an intermediate metabolite, an allosteric regulator, providing building blocks for anabolic pathways, and facilitating protein acetylation. Since acetyl-CoA participates in multiple metabolic pathways, its dysregulation is associated with a wide range of metabolic disorders. In this study, a genetically encoded fluorescence resonance energy transfer (FRET)-based nanosensor was engineered to monitor real-time acetyl CoA levels selectively. The nanosensor, designated as SenACe, enabled the quantification of acetyl CoA dynamics in both in vitro assays and living cells. While examining its selectivity and specificity, SenACe exhibits maximum ratiometric output for acetyl CoA, thereby demonstrating its efficiency as a FRET sensor. The SenACe underwent site-directed mutagenesis to create two mutants, R614A and K880T. Among these nanosensors, the wild-type SenACe-62μ was found to be the most suitable nanosensor, binding acetyl CoA with a binding affinity (Kd) of 0.62 μM and covering a concentration range of 0.1 μM to 20 μM. This variant was further utilized for in vivo real-time analysis of acetyl CoA dynamics in cellular systems (bacteria, yeast, and mammalian cells) via confocal microscopy.
    Keywords:  FRET; acetyl CoA; nanosensor; non-radiative; ratiometric
    DOI:  https://doi.org/10.1016/j.abb.2026.110792
  8. J Proteome Res. 2026 Mar 09.
      Eimeria tenella is a parasitic protozoan with a direct lifecycle in a single host, but with diverse intermediate stages while developing in the host. Each E. tenella developmental stage has distinct structural, pathogenic, genetic, and protein expression, emerging from gene modifications and post-translational modifications (PTMs) of proteins. Ubiquitination regulates diverse cellular functions and activities. Until now, however, there have been sparse data on E. tenella ubiquitination except on some ubiquitin-related enzymes. It is pertinent to unveil the mechanism through which E. tenella developmental stages convert ubiquitin to its development. Herein, the ubiquitome of five life-stages (unsporulated oocyst, early stage of sporulation (i.e., 7 h into sporulation of the oocyst), sporulated oocyst, sporozoite, and second-generation merozoite) of E. tenella was investigated and compared. Correlation analysis of label-free quantitative proteomic and ubiquitomic data was performed. Ubiquitin proteomes were detected and dynamically expressed during the E. tenella oocyst sporulation process and other developmental stages. This implies that protein ubiquitination is perhaps a key regulator of parasite developmental transitions, biology, and pathogenicity. In brief, this study lays the foundation for future in-depth analysis and functional validation of the ubiquitin proteome and modified proteins in the life cycle of the avian parasite. The raw ubiquitome and parallel reaction monitoring (PRM) data sets are accessible via the iProX repository, assigned with accession numbers PXD043159 and PXD067512, respectively.
    Keywords:  4D label-free quantitative proteome; Eimeria tenella; lysine ubiquitin; parallel reaction monitoring; parasite lifecycle; post-translation modification
    DOI:  https://doi.org/10.1021/acs.jproteome.5c01030
  9. FASEB J. 2026 Mar 31. 40(6): e71672
      Trypanosoma cruzi, the causative agent of Chagas disease, possesses glycosomes-unique organelles that house key metabolic enzymes, several of which are promising therapeutic targets. Among them, phosphoenolpyruvate carboxykinase (PEPCK) plays a central role in succinic fermentation, the main pathway for NAD+ regeneration within the organelle. Using CRISPR/Cas9 editing, the PEPCK gene was disrupted in T. cruzi, producing single-allele knockout epimastigotes (TcPEPCK-sKO) with reduced PEPCK expression and enzyme activity. In a high glucose environment, PEPCK disruption impaired glucose consumption and mitochondrial respiration, particularly oxidative phosphorylation, reducing dependence on mitochondrial ATP production when glucose was supplied. To compensate, pyruvate phosphate dikinase was upregulated, increasing alanine production, possibly to maintain redox balance in glycosomes. Despite this metabolic adaptation, the growth of TcPEPCK-sKO epimastigotes was partially reduced compared with non-deleted parasites. In contrast, under low glucose conditions, PEPCK activity was not critical for mitochondrial bioenergetics, ATP production, or proliferation. Although TcPEPCK-sKO epimastigotes exhibited a minor reduction in growth in high glucose medium, their differentiation (metacyclogenesis) and invasion were severely compromised. However, once inside the host cell, TcPEPCK-sKO amastigotes increased their replication, leading to enhanced trypomastigote production. The same was observed in in vivo infection, where TcPEPCK-sKO infection in IFNγ-deficient mice caused uncontrolled parasitemia and severe pathology, highlighting the critical role of PEPCK in host-pathogen interactions. However, an intact immune system effectively contained TcPEPCK-sKO infection. Taken together, our findings demonstrate that glycosomal PEPCK is crucial for coupling glycolysis to mitochondrial bioenergetics, enabling the parasite differentiation within the insect vector and controlling the infection of mammalian host cells.
    Keywords:   Trypanosoma cruzi ; CRISPR/Cas9; bioenergetics; infection; metacyclogenesis; phosphoenolpyruvate carboxykinase
    DOI:  https://doi.org/10.1096/fj.202503541R
  10. Mol Divers. 2026 Mar 12.
      Sirtuin 2 (SIRT2), a NAD+-dependent histone deacetylase implicated in α-synuclein aggregation, is an emerging target for disease-modifying therapies in Parkinson's disease (PD). Here, we employed an integrated computational drug-repurposing strategy to identify potent SIRT2 inhibitors from the DrugBank database. A curated set of 949 inhibitors was used to construct quantitative structure-activity relationship (QSAR) models with four gradient-boosting algorithms, yielding CatBoost as the optimal predictor ([Formula: see text] = 0.74, [Formula: see text] = 0.72). The model screened 4947 drug-like compounds, from which 97 candidates with predicted pIC50 ≥ 6 were prioritized. Molecular docking against the SIRT2 crystal structure (PDB: 4RMG) revealed high-affinity binding modes for multiple hits, notably DB14822, DB03571, and DB06506, engaging conserved residues (Phe119, Tyr139, Phe190, Ile232) through hydrophobic and π-stacking interactions. ADMET profiling indicated favorable drug-likeness and acceptable pharmacokinetic/toxicity properties for most candidates. All-atom molecular dynamics simulations (250 ns) demonstrated that top ligands maintained compact, stable complexes with low RMSD, restricted radius of gyration, and minimal solvent exposure. Principal component and free energy landscape analyses confirmed constrained global motions, while MM/GBSA calculations yielded favorable binding free energies (- 32.6 to - 35.7 kcal/mol) for lead compounds. Given SIRT2's established role in α-synuclein aggregation and neurodegeneration, these compounds represent potential therapeutic starting points for Parkinson's disease and merit experimental validation.
    Keywords:  Drug repurposing; Molecular docking; Molecular dynamics; Parkinson’s disease; QSAR; SIRT2 inhibition
    DOI:  https://doi.org/10.1007/s11030-026-11504-7
  11. EMBO Rep. 2026 Mar 11.
      Increased global protein synthesis is associated with the development and progression of several aging-related diseases and disorders. Strategies like calorie restriction and pharmacological inhibition of protein synthesis have exhibited health-promoting effects. However, the complex molecular events that regulate global protein synthesis are not completely understood. Here, we report that SIRT2, a histone deacetylase, negatively regulates global protein synthesis by inhibiting the mTORC1 pathway via deacetylating Rheb and promoting its degradation. Our in vitro results suggest that SIRT2 deficiency increases protein synthesis, whereas SIRT2 overexpression suppresses protein synthesis. SIRT2-deficient mice exhibit increased global protein synthesis in the hearts, which may contribute to the development of cardiac hypertrophy. Conversely, cardiac-specific overexpression reduces global protein synthesis in the hearts of SIRT2 transgenic mice. Mechanistically, SIRT2 binds to and deacetylates Rheb at K151 residue to enhance ubiquitin-proteosome-mediated degradation of Rheb. Depletion of Rheb rescues increased protein synthesis in SIRT2-inhibited conditions. Our findings suggest that SIRT2 activation could be a potential therapeutic strategy for treating diseases associated with increased protein synthesis.
    Keywords:  Cardiac Hypertrophy; Protein Synthesis; Rheb; SIRT2; Ubiquitination
    DOI:  https://doi.org/10.1038/s44319-026-00724-5
  12. Stem Cell Reports. 2026 Mar 12. pii: S2213-6711(26)00064-0. [Epub ahead of print] 102853
      Preterm white matter injury (PWMI) causes lasting neurological deficits by blocking oligodendrocyte precursor cell (OPC) differentiation. Perinatal hypoxia suppresses mechanistic target of rapamycin complex 1 (mTORC1), essential for OPC maturation. We identify Lipin1 nuclear translocation as a key downstream event of mTORC1 suppression. In PWMI mice, Lipin1 was enriched in OPC nuclei, while primary OPCs and OLN-93 cells showed that mTORC1 inhibition induces Lipin1 dephosphorylation, nuclear accumulation, and impaired differentiation. Mechanistically, nuclear Lipin1 recruits histone deacetylase 2 (HDAC2) to sterol regulatory element-binding protein 1 (SREBP1) target promoters, repressing sphingolipid biosynthesis required for myelination. Lipin1 or HDAC2 knockdown restored SREBP1 targets and OPC differentiation under rapamycin. In vivo, Lipin1 knockdown or HDAC2 inhibition enhanced myelin gene expression, promoted oligodendrocyte maturation, improved myelin ultrastructure, and alleviated motor deficits. Thus, a Lipin1-HDAC2 epigenetic axis mediates hypoxia-induced myelin gene repression, offering targets for white matter repair in preterm infants.
    Keywords:  HDAC2; Lipin1; SREBP1; hypoxia-ischemia; mTORC1 signaling; myelination; oligodendrocyte precursor cells; preterm white matter injury; sphingolipid biosynthesis
    DOI:  https://doi.org/10.1016/j.stemcr.2026.102853